Clinical Trial Results News
Most Popular Clinical Trial Results Story
Analysts give Actelion's key lung drug 63% odds of success
Swiss biotech Actelion ($ATLN) could use a win for its experimental lung drug. In need for a new product to follow its big hit Tracleer, the company's big moment for its lung disease treatment Read more...
Latest Headlines
- January 31, 2012
- December 19, 2011
- December 16, 2011
- September 26, 2011
- April 12, 2011
- April 12, 2011
- April 7, 2011
- April 1, 2011
- March 11, 2011
- February 11, 2011
- January 7, 2011
- January 3, 2011
- October 21, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
